Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension

European Respiratory Journal

Volumn 41, Issue 1, 2013, Pages 224-232

  Delcroix, Marion ^a   Noordegraaf, Anton Vonk ^c   Fadel, Elie ^d   Lang, Irene ^f   Simonneau, Gérald ^e   Naeijee, Robert ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chronic thromboembolic pulmonary hypertension; Gas exchange; Pulmonary arterial hypertension; Pulmonary circulation; Remodelling; Right ventricular function

Indexed keywords

ARTERIAL CARBON DIOXIDE TENSION; ARTERY DISEASE; ARTICLE; AUGMENTATION INDEX; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR DISEASE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC DYSFUNCTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; ENDARTERECTOMY; EXPERIMENTAL MODEL; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE OVERLOAD; HEART VENTRICLE COMPLIANCE; HUMAN; HYPERCAPNIA; HYPERVENTILATION; LUNG ANGIOGRAPHY; LUNG DEAD SPACE; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; LUNG VENTILATION; NONHUMAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VALVE INSUFFICIENCY; PULSE PRESSURE; SENSITIVITY AND SPECIFICITY;

ANIMALS; BLOOD VESSELS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION, PULMONARY; THROMBOEMBOLISM; VENTRICULAR REMODELING;

EID: 84872185380     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00047712     Document Type: Article

References (76)

1. Hoeper MM. Chronic thromboembolic pulmonary hypertension. Circulation 2006; 113: 2011-2020.
2. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124: 1973-1981.
3. Mayer E. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006; 3: 589-593.
4. Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141: 702-710.
5. Lang IM, Marsh JJ, Konopka RG, et al. Factors contributing to increased vascular fibrinolytic activity in mongrel dogs. Circulation 1993; 87: 1990-2000.
6. Mitzner W, Wagner EM. Vascular remodeling in the circulations of the lung. J Appl Physiol 2004; 97: 1999-2004.
7. Moser KM, Cantor JP, Olman M, et al. Chronic pulmonary thromboembolism in dogs treated with tranexamic acid. Circulation 1991; 83: 1371-1379.
8. Marsh JJ, Konopka RG, Lang IM, et al. Suppression of thrombolysis in a canine model of pulmonary embolism. Circulation 1994; 90: 3091-3097.
9. Fadel E, Mazmanian GM, Chapelier A, et al. Lung reperfusion injury after chronic or acute unilateral pulmonary artery occlusion. Am J Respir Crit Care Med 1998; 157: 1294-1300.
10. Mercier O, Tivane A, Raoux F, et al. A reliable piglet model of chronic thrombo-embolic pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: A2415.
11. Rondelet B, Kerbaul F, Motte S, et al. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 2003; 107: 1329-1335.
12. Mercier O, Sage E, de Perrot M, et al. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets. J Thorac Cardiovasc Surg 2009; 137: 1538-1546.
13. Arbustini E, Morbini P, D'armini AM, et al. Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002; 88: 177-182.
14. Bernard J, Yi ES. Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution. Hum Pathol 2007; 38: 871-877.
15. Blauwet LA, Edwards WD, Tazelaar HD, et al. Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Hum Pathol 2003; 34: 1290-1298.
16. Lang I, Pesavento R, Bonderman D, et al. Risk factors and basic mechanism of CTEPH - a current understanding. Eur Respir J 2012; [Epub ahead of print DOI: 10.1183/09031936.00049312].
17. Azarian R, Wartski M, Collignon MA, et al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997; 38: 980-983.
18. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685-692.
19. Kim H, Yung GL, Marsh JJ, et al. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res 2000; 26: 287-301.
20. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160: 523-528.
21. Hakim TS, Michel RP, Chang HK. Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. J Appl Physiol 1982; 52: 710-715.
22. Hakim TS, Kelly S. Occlusion pressures vs. micropipette pressures in the pulmonary circulation. J Appl Physiol 1989; 67: 1277-1285.
23. Fesler P, Pagnamenta A, Vachiéry JL, et al. Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J 2003; 21: 31-36.
24. Kim NHS, Fesler P, Channick RN, et al. Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Circulation 2004; 109: 18-22.
25. Toshner M, Suntharalingam J, Fesler P, et al. Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH. Eur Respir J 2012; 40: 612-617.
26. Jiang X, Khan M, Tian W, et al. Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection. J Clin Invest 2011; 121: 2336-2349.
27. Pettersson G, Norgaard M, Arendrup H, et al. Direct bronchial artery revascularization and en bloc double lung transplantation - surgical techniques and early outcome. J Heart Lung Transplant 1997; 16: 320-333.
28. Cantu JA, Safdar Z. Hemoptysis requiring bronchial artery embolization in pulmonary arterial hypertension. South Med J 2010; 103: 887-891.
29. Michel RP, Hakim TS, Petsikas D. Segmental vascular resistance in postobstructive pulmonary vasculopathy. J Appl Physiol 1990; 69: 1022-1032.
30. Endrys J, Hayat N, Cherian G. Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension. Heart 1997; 78: 171-176.
31. Shimizu H, Tanabe N, Terada J, et al. Dilatation of bronchial arteries correlates with extent of central disease in patients with chronic thromboembolic pulmonary hypertension. Circ J 2008; 72: 1136-1141.
32. Ley S, Kreitner K-F, Morgenstern I, et al. Bronchopulmonary shunts in patients with chronic thromboembolic pulmonary hypertension: evaluation with helical CT and MR imaging. AJR Am J Roentgenol 2002; 179: 1209-1215.
33. Kauczor HU, Schwickert HC, Mayer E, et al. Spiral CT of bronchial arteries in chronic thromboembolism. J Comput Assist Tomogr 1994; 18: 855-861.
34. Thistlethwaite PA, Mo M, Madani MM, et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002; 124: 1203-1211.
35. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
36. Charan N, Turk G, Dhand R. The role of bronchial circulation in lung abscess. Am Rev Respir Dis 1985; 131: 121-124.
37. Charan NB, Carvalho P. Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction. J Appl Physiol 1997; 82: 284-291.
38. Zhou G, Dada LA, Wu M, et al. Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. AJP Lung Cell Mol Physiol 2009; 297: L1120-L1130.
39. Wilkes DS. Chronic lung allograft rejection and airway microvasculature: is HIF-1 the missing link?J Clin Invest 2011; 121: 2155-2157.
40. Furuno Y, Nagamoto Y, Fujita M, et al. Reflection as a cause of midsystolic deceleration of pulmonary flow wave in dogs with acute pulmonary hypertension: comparison of pulmonary artery constriction with pulmonary embolisation. Cardiovasc Res 1991; 25: 118-124.
41. Nakayama Y, Nakanishi N, Sugimachi M, et al. Characteristics of pulmonary artery pressure waveform for differential diagnosis of chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol 1997; 29: 1311-1316.
42. Nakayama Y, Sugimachi M, Nakanishi N, et al. Noninvasive differential diagnosis between chronic pulmonary thromboembolism and primary pulmonary hypertension by means of Doppler ultrasound measurement. J Am Coll Cardiol 1998; 31: 1367-1371.
43. Nakayama Y, Nakanishi N, Hayashi T, et al. Pulmonary artery reflection for differentially diagnosing primary pulmonary hypertension and chronic pulmonary thromboembolism. J Am Coll Cardiol 2001; 38: 214-218.
44. Castelain V, Herve P, Lecarpentier Y, et al. Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. J Am Coll Cardiol 2001; 37: 1085-1092.
45. Chemla D, Castelain V, Humbert M, et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 2004; 126: 1313-1317.
46. Lankhaar J-W, Westerhof N, Faes TJC, et al. Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J PhysiolHeart Circ Physiol 2006; 291:H1731-H1737.
47. Lankhaar J-W, Westerhof N, Faes TJC, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J 2008; 29: 1688-1695.
48. Bonderman D, Martischnig AM, Vonbank K, et al. Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy. Chest 2011; 139: 122-127.
49. de Perrot M, McRae K, Shargall Y, et al. Early postoperative pulmonary vascular compliance predicts outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Chest 2011; 140: 34-41.
50. Saouti N, Westerhof N, Helderman F, et al. RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009; 297: H2154-H2160.
51. Saouti N, Westerhof N, Helderman F, et al. Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med 2010; 182: 1315-1320.
52. Hardziyenka M, Reesink HJ, Bouma BJ, et al. A novel echocardiographic predictor of in-hospital mortality and mid-term haemodynamic improvement after pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension. Eur Heart J 2007; 28: 842-849.
53. Naeije R, Huez S. Reflections on wave reflections in chronic thromboembolic pulmonary hypertension. Eur Heart J 2007; 28: 785-787.
54. Arkles JS, Opotowsky AR, Ojeda J, et al. Shape of the right ventricular Doppler envelope predicts hemodynamics and right heart function in pulmonary hypertension. Am J Respir Crit Care Med 2011; 183: 268-276.
55. Bogaard HJ, Abe K, Vonk Noordegraaf A, et al. The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. Chest 2009; 135: 794-804.
56. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114: 1883-1891.
57. Reesink HJ, Marcus JT, Tulevski II, et al. Reverse right ventricular remodeling after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: utility of magnetic resonance imaging to demonstrate restoration of the right ventricle. J Thorac Cardiovasc Surg 2007; 133: 58-64.
58. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007; 28: 1250-1257.
59. Quarck R, Nawrot T, Meyns B, et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 53: 1211-1218.
60. Jais X, D'Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol 2008; 52: 2127-2134.
61. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
62. Handoko ML, De Man FS, Allaart CP, et al. Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart. Eur Respir Rev 2010; 19: 72-82.
63. Mauritz G-J, Vonk-Noordegraaf A, Kind T, et al. Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress. J Cardiovasc Magn Reson 2012; 14: 5.
64. Surie S, Bouma BJ, Bruin-Bon RAH, Hardziyenka M, et al. Time course of restoration of systolic and diastolic right ventricular function after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Am Heart J 2011; 161: 1046-1052.
65. Iino M, Dymarkowski S, Chaothawee L, et al. Time course of reversed cardiac remodeling after pulmonary endarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 2008; 18: 792-799.
66. Giusca S, Dambrauskaite V, Scheurwegs C, et al. Deformation imaging describes right ventricular function better than longitudinal displacement of the tricuspid ring. Heart 2010; 96: 281-288.
67. D'Alonzo GE, Bower JS, Dantzker DR. Differentiation of patients with primary and thromboembolic pulmonary hypertension. Chest 1984; 85: 457-461.
68. Dantzker DR, Bower JS. Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease. J Clin Invest 1979; 64: 1050-1055.
69. Dantzker DR, D'Alonzo GE, Bower JS, et al. Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. Am Rev Respir Dis 1984; 130: 412-416.
70. Mélot C, Naeije R, Mols P, et al. Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest 1983; 83: 203-207.
71. Kapitan KS, Buchbinder M, Wagner PD, et al. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis 1989; 139: 1149-1154.
72. Kapitan KS, Clausen JL, Moser KM. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy. Chest 1990; 98: 14-19.
73. Mélot C, Naeije R. Pulmonary vascular diseases. Comp Physiol 2011; 1: 593-619.
74. Hoeper MM, Pletz MW, Golpon H, et al. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2007; 29: 944-950.
75. Naeije R, van de Borne P. Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J 2009; 34: 792-794.
76. Zhai Z, Murphy K, Tighe H, et al. Differences in ventilatory inefficiency between pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest 2011; 140: 1284-1291.